What Changes Can We Expect Around Drug & Prescription Protocols?
When dental offices finally emerge from the COVID-19 pandemic, much will have changed. And though none of us has a crystal ball, it is clear that the future of dentistry is evolving before our eyes.
So, what about pharmacological protocols? Will the way we prescribe drugs be radically changed?
In this short interview, Dr. Mark Donaldson, Senior Executive Director, Vizient, speaks to Chiraz Guessaier, CDA, about the impact the pandemic will have on the drugs we prescribe in the dental office.
In the hope that dental offices will open sooner rather than later, Dr. Donaldson stresses the importance of knowing what we don’t know. He addresses concerns over recent reports on the use of Ibuprofen, as well as the question of Point-of-Care testing. And, he assures dentists that there is much that will not change, such as the use of nitrous oxide, local anesthetic, and existing pain management guidelines.
We hope you find the conversation useful. We welcome your thoughts, questions and/or suggestions about this post and other topics. Leave a comment in the box below or send us your feedback by email.
Until next time!
Chiraz Guessaier, CDA Oasis Manager